APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Neurorehabilitation

Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system.

Explore the product
View pricing & licenses

Product & engineering

Understand the product.

The research object may be an ingredient, device, preparation or care service. These supply stages have different specifications and measurement units; an ingredient identity or device name does not establish a clinical outcome.

What turns activity into demand

Qualified use at the specified treatment or instrument boundary creates purchases through protocol, utilisation and replacement. A product, clinical service and complete care episode measure different supplied objects.

The commercial boundary

For Neurorehabilitation, distinguish the supplied service or configured system from its inputs and the complete application. Report types and applications may overlap; retain the selected edition's product definition, geography, period, unit and transaction basis when comparing estimates.

Which conditions determine usable neurorehabilitation performance?

Neurorehabilitation refers to a structured, multidisciplinary set of medical and therapy interventions that aim to restore, compensate for, or optimize neurological function and participation after injury or disease of the central or peripheral nervous system. Confirm the specified composition or device function, intended use and supplied unit. Separate ingredients, finished preparations, equipment and treatment activity before comparing quantities or revenue; use the report scope rather than inferring efficacy from an illustration.

Selected research

Market Analysis & Forecast

Global Neurorehabilitation Market Analysis and Forecast 2026-2032

Report ID 17389496021 January 2026199 pages

Choose your research edition.

Industry ResearchNeurorehabilitation Industry Research Report 2026120 pages · $2,950 USDIndustry Growth & TrendsGlobal Neurorehabilitation Industry Growth and Trends Forecast to 2032102 pages · $3,450 USDMarket StructureGlobal Neurorehabilitation Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032197 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Neurorehabilitation Market Outlook and Growth Opportunities 2026193 pages · $4,250 USDMarket Analysis & ForecastGlobal Neurorehabilitation Market Analysis and Forecast 2026-2032199 pages · $4,950 USD

Market perspective

The global Neurorehabilitation market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The North America market for Neurorehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Neurorehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Neurorehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Neurorehabilitation is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global companies of Neurorehabilitation include VISHEE, Beijing Bo'ai Hospital, Beijing Rehabilitation Hospital of Capital Medical University, NCC, CHIEFTAIN, Tongji Hospital, Haobro Medical Device, DIH and Sun Java, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

Report Includes

This report presents an overview of global market for Neurorehabilitation, market size. Analyses of the global market trends, with historic market revenue data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Neurorehabilitation, also provides the revenue of main regions and countries. Of the upcoming market potential for Neurorehabilitation, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Neurorehabilitation revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Neurorehabilitation market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, revenue, and growth rate, from 2021 to 2032. Evaluation and forecast the market size for Neurorehabilitation revenue, projected growth trends, production technology, application and end-user industry.

Neurorehabilitation Segment by Company

VISHEE

Beijing Bo'ai Hospital

Beijing Rehabilitation Hospital of Capital Medical University

NCC

CHIEFTAIN

Tongji Hospital

Haobro Medical Device

DIH

Sun Java

Aoyang Health

PKUCare Rehabilitation Hospital

Beijing Puhua International Hospital

Xiangyu Medical

Beijing United Family Rehabilitation Hospital

Neurorehabilitation Segment by Type

Brain Injury

Spinal Cord Injury

Peripheral Nerve Injury

Other

Neurorehabilitation Segment by Application

General Hospital

Rehabilitation Specialist Hospital

Community Rehabilitation Center

Neurorehabilitation Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key players, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Neurorehabilitation market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Neurorehabilitation and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in market size), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Neurorehabilitation.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Revenue of Neurorehabilitation in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 4: Detailed analysis of Neurorehabilitation company competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Neurorehabilitation revenue, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, revenue for each segment.

Chapter 9: Europe by type, by application and by country, revenue for each segment.

Chapter 10: China type, by application, revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, revenue for each segment.

Chapter 13: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Neurorehabilitation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Brain Injury Major Player Table 3. Spinal Cord Injury Major Player Table 4. Peripheral Nerve Injury Major Player Table 5. Other Major Player Table 6. Global Neurorehabilitation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 7. General Hospital Major Player Table 8. Rehabilitation Specialist Hospital Major Player Table 9. Community Rehabilitation Center Major Player Table 10. Neurorehabilitation Industry Trends Table 11. Neurorehabilitation Industry Drivers Table 12. Neurorehabilitation Industry Opportunities and Challenges Table 13. Neurorehabilitation Industry Restraints Table 14. Global Neurorehabilitation Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 15. Global Neurorehabilitation Market Size by Region (2021-2026) & (US$ Million) Table 16. Global Neurorehabilitation Market Share by Region (2021-2026) Table 17. Global Neurorehabilitation Market Size by Region (2027-2032) & (US$ Million) Table 18. Global Neurorehabilitation Market Share by Region (2027-2032) Table 19. Global Neurorehabilitation Revenue by Players (US$ Million) & (2021-2026) Table 20. Global Neurorehabilitation Revenue Market Share by Players (2021-2026) Table 21. Global Neurorehabilitation Key Players Ranking, 2024 VS 2025 VS 2026 Table 22. Global Neurorehabilitation Key Players Headquarters & Area Served Table 23. Global Neurorehabilitation Players, Product Type & Application Table 24. Global Neurorehabilitation Players Establishment Date Table 25. Global Players Market Concentration Ratio (CR5 and HHI) Table 26. Global Neurorehabilitation by Players Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 27. Global Neurorehabilitation Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 28. Global Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 29. Global Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 30. Global Neurorehabilitation Revenue Market Share by Type (2021-2026) Table 31. Global Neurorehabilitation Revenue Market Share by Type (2027-2032) Table 32. Global Neurorehabilitation Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 33. Global Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 34. Global Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 35. Global Neurorehabilitation Revenue Market Share by Application (2021-2026) Table 36. Global Neurorehabilitation Revenue Market Share by Application (2027-2032) Table 37. VISHEE Company Information Table 38. VISHEE Business Overview Table 39. VISHEE Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 40. VISHEE Neurorehabilitation Product Portfolio Table 41. VISHEE Recent Development Table 42. Beijing Bo'ai Hospital Company Information Table 43. Beijing Bo'ai Hospital Business Overview Table 44. Beijing Bo'ai Hospital Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 45. Beijing Bo'ai Hospital Neurorehabilitation Product Portfolio Table 46. Beijing Bo'ai Hospital Recent Development Table 47. Beijing Rehabilitation Hospital of Capital Medical University Company Information Table 48. Beijing Rehabilitation Hospital of Capital Medical University Business Overview Table 49. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 50. Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Product Portfolio Table 51. Beijing Rehabilitation Hospital of Capital Medical University Recent Development Table 52. NCC Company Information Table 53. NCC Business Overview Table 54. NCC Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 55. NCC Neurorehabilitation Product Portfolio Table 56. NCC Recent Development Table 57. CHIEFTAIN Company Information Table 58. CHIEFTAIN Business Overview Table 59. CHIEFTAIN Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 60. CHIEFTAIN Neurorehabilitation Product Portfolio Table 61. CHIEFTAIN Recent Development Table 62. Tongji Hospital Company Information Table 63. Tongji Hospital Business Overview Table 64. Tongji Hospital Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 65. Tongji Hospital Neurorehabilitation Product Portfolio Table 66. Tongji Hospital Recent Development Table 67. Haobro Medical Device Company Information Table 68. Haobro Medical Device Business Overview Table 69. Haobro Medical Device Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 70. Haobro Medical Device Neurorehabilitation Product Portfolio Table 71. Haobro Medical Device Recent Development Table 72. DIH Company Information Table 73. DIH Business Overview Table 74. DIH Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 75. DIH Neurorehabilitation Product Portfolio Table 76. DIH Recent Development Table 77. Sun Java Company Information Table 78. Sun Java Business Overview Table 79. Sun Java Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 80. Sun Java Neurorehabilitation Product Portfolio Table 81. Sun Java Recent Development Table 82. Aoyang Health Company Information Table 83. Aoyang Health Business Overview Table 84. Aoyang Health Neurorehabilitation Revenue and Gross Margin (US$ Million) & (2021-2026) Table 85. Aoyang Health Neurorehabilitation Product Portfolio Table 86. Aoyang Health Recent Development Table 87. PKUCare Rehabilitation Hospital Company Information Table 88. PKUCare Rehabilitation Hospital Business Overview Table 89. PKUCare Rehabilitation Hospital Neurorehabilitation Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 90. PKUCare Rehabilitation Hospital Neurorehabilitation Product Portfolio Table 91. PKUCare Rehabilitation Hospital Recent Development Table 92. Beijing Puhua International Hospital Company Information Table 93. Beijing Puhua International Hospital Business Overview Table 94. Beijing Puhua International Hospital Neurorehabilitation Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 95. Beijing Puhua International Hospital Neurorehabilitation Product Portfolio Table 96. Beijing Puhua International Hospital Recent Development Table 97. Xiangyu Medical Company Information Table 98. Xiangyu Medical Business Overview Table 99. Xiangyu Medical Neurorehabilitation Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 100. Xiangyu Medical Neurorehabilitation Product Portfolio Table 101. Xiangyu Medical Recent Development Table 102. Beijing United Family Rehabilitation Hospital Company Information Table 103. Beijing United Family Rehabilitation Hospital Business Overview Table 104. Beijing United Family Rehabilitation Hospital Neurorehabilitation Sales (), Revenue (US$ Million), Price () and Gross Margin (2021-2026) Table 105. Beijing United Family Rehabilitation Hospital Neurorehabilitation Product Portfolio Table 106. Beijing United Family Rehabilitation Hospital Recent Development Table 107. North America Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 108. North America Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 109. North America Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 110. North America Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 111. North America Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 112. North America Neurorehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 113. North America Neurorehabilitation Revenue by Country (US$ Million) & (2027-2032) Table 114. Europe Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 115. Europe Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 116. Europe Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 117. Europe Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 118. Europe Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 119. Europe Neurorehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 120. Europe Neurorehabilitation Revenue by Country (US$ Million) & (2027-2032) Table 121. China Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 122. China Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 123. China Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 124. China Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 125. Asia Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 126. Asia Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 127. Asia Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 128. Asia Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 129. Asia Neurorehabilitation Revenue by Region (2021 VS 2025 VS 2032) & (US$ Million) Table 130. Asia Neurorehabilitation Revenue by Region (US$ Million) & (2021-2026) Table 131. Asia Neurorehabilitation Revenue by Region (US$ Million) & (2027-2032) Table 132. SAMEA Neurorehabilitation Revenue by Type (2021-2026) & (US$ Million) Table 133. SAMEA Neurorehabilitation Revenue by Type (2027-2032) & (US$ Million) Table 134. SAMEA Neurorehabilitation Revenue by Application (2021-2026) & (US$ Million) Table 135. SAMEA Neurorehabilitation Revenue by Application (2027-2032) & (US$ Million) Table 136. SAMEA Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 137. SAMEA Neurorehabilitation Revenue by Country (2021-2026) & (US$ Million) Table 138. SAMEA Neurorehabilitation Revenue by Country (US$ Million) & (2027-2032) Table 139. Research Programs/Design for This Report Table 140. Authors List of This Report Table 141. Secondary Sources Table 142. Primary Sources List of Figures Figure 1. Neurorehabilitation Image Figure 2. Global Neurorehabilitation Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Neurorehabilitation Market Size Share 2021 VS 2025 VS 2032 Figure 4. Brain Injury Image Figure 5. Spinal Cord Injury Image Figure 6. Peripheral Nerve Injury Image Figure 7. Other Image Figure 8. Global Neurorehabilitation Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 9. Global Neurorehabilitation Market Size Share 2021 VS 2025 VS 2032 Figure 10. General Hospital Image Figure 11. Rehabilitation Specialist Hospital Image Figure 12. Community Rehabilitation Center Image Figure 13. Global Neurorehabilitation Market Size (US$ Million) & (2021-2032) Figure 14. Global Neurorehabilitation Market Size, (US$ Million), 2021 VS 2025 VS 2032 Figure 15. Global Neurorehabilitation Market Share by Region: 2021 VS 2025 VS 2032 Figure 16. Global Neurorehabilitation Players Revenue Share Top 10 and Top 5 in 2025 Figure 17. Players Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 18. Global Neurorehabilitation Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 19. Global Neurorehabilitation Revenue Market Share 2021 VS 2025 VS 2032 Figure 20. Global Neurorehabilitation Revenue Market Share by Type (2021-2032) Figure 21. Global Neurorehabilitation Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 22. Global Neurorehabilitation Revenue Market Share by Application (2021 VS 2025 VS 2032) Figure 23. Global Neurorehabilitation Revenue Market Share by Application (2021-2032) Figure 24. North America Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 25. North America Neurorehabilitation Revenue Share by Type (2021-2032) Figure 26. North America Neurorehabilitation Revenue Share by Application (2021-2032) Figure 27. North America Neurorehabilitation Revenue Share by Country (2021-2032) Figure 28. United States Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 29. Canada Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 30. Mexico Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 31. Europe Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 32. Europe Neurorehabilitation Revenue Share by Type (2021-2032) Figure 33. Europe Neurorehabilitation Revenue Share by Application (2021-2032) Figure 34. Europe Neurorehabilitation Revenue Share by Country (2021-2032) Figure 35. Germany Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 36. France Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 37. U.K. Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 38. Italy Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 39. Spain Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 40. Russia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 41. Netherlands Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 42. Nordic Countries Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 43. China Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 44. China Neurorehabilitation Revenue Share by Type (2021-2032) Figure 45. China Neurorehabilitation Revenue Share by Application (2021-2032) Figure 46. Asia Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 47. Asia Neurorehabilitation Revenue Share by Type (2021-2032) Figure 48. Asia Neurorehabilitation Revenue Share by Application (2021-2032) Figure 49. Asia Neurorehabilitation Revenue Share by Region (2021-2032) Figure 50. Japan Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 51. South Korea Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 52. India Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 53. Australia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 54. Taiwan Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 55. Southeast Asia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 56. SAMEA Neurorehabilitation Revenue YoY Growth (2021-2032) & (US$ Million) Figure 57. SAMEA Neurorehabilitation Revenue Share by Type (2021-2032) Figure 58. SAMEA Neurorehabilitation Revenue Share by Application (2021-2032) Figure 59. SAMEA Neurorehabilitation Revenue Share by Country (2021-2032) Figure 60. Brazil Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 61. Argentina Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 62. Chile Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 63. Colombia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 64. Peru Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 65. Saudi Arabia Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 66. Israel Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 67. UAE Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 68. Turkey Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 69. Iran Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 70. Egypt Neurorehabilitation Revenue YoY Growth (US$ Million) & (2021-2032) Figure 71. Years Considered Figure 72. Research Process Figure 73. Key Executives Interviewed

Scope & coverage.

Types
  • Brain Injury
  • Spinal Cord Injury
  • Peripheral Nerve Injury
  • Other
Applications
  • General Hospital
  • Rehabilitation Specialist Hospital
  • Community Rehabilitation Center
Companies covered
  • VISHEE
  • Beijing Bo'ai Hospital
  • Beijing Rehabilitation Hospital of Capital Medical University
  • NCC
  • CHIEFTAIN
  • Tongji Hospital
  • Haobro Medical Device
  • DIH
  • Sun Java
  • Aoyang Health
  • PKUCare Rehabilitation Hospital
  • Beijing Puhua International Hospital
  • Xiangyu Medical
  • Beijing United Family Rehabilitation Hospital

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Neurorehabilitation Market by Type
  3. 1.2.1 Global Neurorehabilitation Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Brain Injury
  5. 1.2.3 Spinal Cord Injury
  6. 1.2.4 Peripheral Nerve Injury
  7. 1.2.5 Other
  8. 1.3 Neurorehabilitation Market by Application
  9. 1.3.1 Global Neurorehabilitation Market Size by Application, 2021 VS 2025 VS 2032
  10. 1.3.2 General Hospital
  11. 1.3.3 Rehabilitation Specialist Hospital
  12. 1.3.4 Community Rehabilitation Center
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Neurorehabilitation Market Dynamics
  1. 2.1 Neurorehabilitation Industry Trends
  2. 2.2 Neurorehabilitation Industry Drivers
  3. 2.3 Neurorehabilitation Industry Opportunities and Challenges
  4. 2.4 Neurorehabilitation Industry Restraints
3 Global Growth Perspective
  1. 3.1 Global Neurorehabilitation Market Perspective (2021-2032)
  2. 3.2 Global Neurorehabilitation Growth Trends by Region
  3. 3.2.1 Global Neurorehabilitation Market Size by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Neurorehabilitation Market Size by Region (2021-2026)
  5. 3.2.3 Global Neurorehabilitation Market Size by Region (2027-2032)
4 Competitive Landscape by Players
  1. 4.1 Global Neurorehabilitation Revenue by Players
  2. 4.1.1 Global Neurorehabilitation Revenue by Players (2021-2026)
  3. 4.1.2 Global Neurorehabilitation Revenue Market Share by Players (2021-2026)
  4. 4.1.3 Global Neurorehabilitation Players Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Neurorehabilitation Key Players Ranking, 2024 VS 2025 VS 2026
  6. 4.3 Global Neurorehabilitation Key Players Headquarters & Area Served
  7. 4.4 Global Neurorehabilitation Players, Product Type & Application
  8. 4.5 Global Neurorehabilitation Players Establishment Date
  9. 4.6 Market Competitive Analysis
  10. 4.6.1 Global Neurorehabilitation Market CR5 and HHI
  11. 4.6.3 2025 Neurorehabilitation Tier 1, Tier 2, and Tier 3
5 Neurorehabilitation Market Size by Type
  1. 5.1 Global Neurorehabilitation Revenue by Type (2021 VS 2025 VS 2032)
  2. 5.2 Global Neurorehabilitation Revenue by Type (2021-2032)
  3. 5.3 Global Neurorehabilitation Revenue Market Share by Type (2021-2032)
6 Neurorehabilitation Market Size by Application
  1. 6.1 Global Neurorehabilitation Revenue by Application (2021 VS 2025 VS 2032)
  2. 6.2 Global Neurorehabilitation Revenue by Application (2021-2032)
  3. 6.3 Global Neurorehabilitation Revenue Market Share by Application (2021-2032)
7 Company Profiles
  1. 7.1 VISHEE
  2. 7.1.1 VISHEE Company Information
  3. 7.1.2 VISHEE Business Overview
  4. 7.1.3 VISHEE Neurorehabilitation Revenue and Gross Margin (2021-2026)
  5. 7.1.4 VISHEE Neurorehabilitation Product Portfolio
  6. 7.1.5 VISHEE Recent Developments
  7. 7.2 Beijing Bo'ai Hospital
  8. 7.2.1 Beijing Bo'ai Hospital Company Information
  9. 7.2.2 Beijing Bo'ai Hospital Business Overview
  10. 7.2.3 Beijing Bo'ai Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  11. 7.2.4 Beijing Bo'ai Hospital Neurorehabilitation Product Portfolio
  12. 7.2.5 Beijing Bo'ai Hospital Recent Developments
  13. 7.3 Beijing Rehabilitation Hospital of Capital Medical University
  14. 7.3.1 Beijing Rehabilitation Hospital of Capital Medical University Company Information
  15. 7.3.2 Beijing Rehabilitation Hospital of Capital Medical University Business Overview
  16. 7.3.3 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Revenue and Gross Margin (2021-2026)
  17. 7.3.4 Beijing Rehabilitation Hospital of Capital Medical University Neurorehabilitation Product Portfolio
  18. 7.3.5 Beijing Rehabilitation Hospital of Capital Medical University Recent Developments
  19. 7.4 NCC
  20. 7.4.1 NCC Company Information
  21. 7.4.2 NCC Business Overview
  22. 7.4.3 NCC Neurorehabilitation Revenue and Gross Margin (2021-2026)
  23. 7.4.4 NCC Neurorehabilitation Product Portfolio
  24. 7.4.5 NCC Recent Developments
  25. 7.5 CHIEFTAIN
  26. 7.5.1 CHIEFTAIN Company Information
  27. 7.5.2 CHIEFTAIN Business Overview
  28. 7.5.3 CHIEFTAIN Neurorehabilitation Revenue and Gross Margin (2021-2026)
  29. 7.5.4 CHIEFTAIN Neurorehabilitation Product Portfolio
  30. 7.5.5 CHIEFTAIN Recent Developments
  31. 7.6 Tongji Hospital
  32. 7.6.1 Tongji Hospital Company Information
  33. 7.6.2 Tongji Hospital Business Overview
  34. 7.6.3 Tongji Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  35. 7.6.4 Tongji Hospital Neurorehabilitation Product Portfolio
  36. 7.6.5 Tongji Hospital Recent Developments
  37. 7.7 Haobro Medical Device
  38. 7.7.1 Haobro Medical Device Company Information
  39. 7.7.2 Haobro Medical Device Business Overview
  40. 7.7.3 Haobro Medical Device Neurorehabilitation Revenue and Gross Margin (2021-2026)
  41. 7.7.4 Haobro Medical Device Neurorehabilitation Product Portfolio
  42. 7.7.5 Haobro Medical Device Recent Developments
  43. 7.8 DIH
  44. 7.8.1 DIH Company Information
  45. 7.8.2 DIH Business Overview
  46. 7.8.3 DIH Neurorehabilitation Revenue and Gross Margin (2021-2026)
  47. 7.8.4 DIH Neurorehabilitation Product Portfolio
  48. 7.8.5 DIH Recent Developments
  49. 7.9 Sun Java
  50. 7.9.1 Sun Java Company Information
  51. 7.9.2 Sun Java Business Overview
  52. 7.9.3 Sun Java Neurorehabilitation Revenue and Gross Margin (2021-2026)
  53. 7.9.4 Sun Java Neurorehabilitation Product Portfolio
  54. 7.9.5 Sun Java Recent Developments
  55. 7.10 Aoyang Health
  56. 7.10.1 Aoyang Health Company Information
  57. 7.10.2 Aoyang Health Business Overview
  58. 7.10.3 Aoyang Health Neurorehabilitation Revenue and Gross Margin (2021-2026)
  59. 7.10.4 Aoyang Health Neurorehabilitation Product Portfolio
  60. 7.10.5 Aoyang Health Recent Developments
  61. 7.11 PKUCare Rehabilitation Hospital
  62. 7.11.1 PKUCare Rehabilitation Hospital Company Information
  63. 7.11.2 PKUCare Rehabilitation Hospital Business Overview
  64. 7.11.3 PKUCare Rehabilitation Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  65. 7.11.4 PKUCare Rehabilitation Hospital Neurorehabilitation Product Portfolio
  66. 7.11.5 PKUCare Rehabilitation Hospital Recent Developments
  67. 7.12 Beijing Puhua International Hospital
  68. 7.12.1 Beijing Puhua International Hospital Company Information
  69. 7.12.2 Beijing Puhua International Hospital Business Overview
  70. 7.12.3 Beijing Puhua International Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  71. 7.12.4 Beijing Puhua International Hospital Neurorehabilitation Product Portfolio
  72. 7.12.5 Beijing Puhua International Hospital Recent Developments
  73. 7.13 Xiangyu Medical
  74. 7.13.1 Xiangyu Medical Company Information
  75. 7.13.2 Xiangyu Medical Business Overview
  76. 7.13.3 Xiangyu Medical Neurorehabilitation Revenue and Gross Margin (2021-2026)
  77. 7.13.4 Xiangyu Medical Neurorehabilitation Product Portfolio
  78. 7.13.5 Xiangyu Medical Recent Developments
  79. 7.14 Beijing United Family Rehabilitation Hospital
  80. 7.14.1 Beijing United Family Rehabilitation Hospital Company Information
  81. 7.14.2 Beijing United Family Rehabilitation Hospital Business Overview
  82. 7.14.3 Beijing United Family Rehabilitation Hospital Neurorehabilitation Revenue and Gross Margin (2021-2026)
  83. 7.14.4 Beijing United Family Rehabilitation Hospital Neurorehabilitation Product Portfolio
  84. 7.14.5 Beijing United Family Rehabilitation Hospital Recent Developments
8 North America
  1. 8.1 North America Neurorehabilitation Revenue (2021-2032)
  2. 8.2 North America Neurorehabilitation Revenue by Type (2021-2032)
  3. 8.2.1 North America Neurorehabilitation Revenue by Type (2021-2026)
  4. 8.2.2 North America Neurorehabilitation Revenue by Type (2027-2032)
  5. 8.3 North America Neurorehabilitation Revenue Share by Type (2021-2032)
  6. 8.4 North America Neurorehabilitation Revenue by Application (2021-2032)
  7. 8.4.1 North America Neurorehabilitation Revenue by Application (2021-2026)
  8. 8.4.2 North America Neurorehabilitation Revenue by Application (2027-2032)
  9. 8.5 North America Neurorehabilitation Revenue Share by Application (2021-2032)
  10. 8.6 North America Neurorehabilitation Revenue by Country
  11. 8.6.1 North America Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032)
  12. 8.6.2 North America Neurorehabilitation Revenue by Country (2021-2026)
  13. 8.6.3 North America Neurorehabilitation Revenue by Country (2027-2032)
  14. 8.6.4 United States
  15. 8.6.5 Canada
  16. 8.6.6 Mexico
9 Europe
  1. 9.1 Europe Neurorehabilitation Revenue (2021-2032)
  2. 9.2 Europe Neurorehabilitation Revenue by Type (2021-2032)
  3. 9.2.1 Europe Neurorehabilitation Revenue by Type (2021-2026)
  4. 9.2.2 Europe Neurorehabilitation Revenue by Type (2027-2032)
  5. 9.3 Europe Neurorehabilitation Revenue Share by Type (2021-2032)
  6. 9.4 Europe Neurorehabilitation Revenue by Application (2021-2032)
  7. 9.4.1 Europe Neurorehabilitation Revenue by Application (2021-2026)
  8. 9.4.2 Europe Neurorehabilitation Revenue by Application (2027-2032)
  9. 9.5 Europe Neurorehabilitation Revenue Share by Application (2021-2032)
  10. 9.6 Europe Neurorehabilitation Revenue by Country
  11. 9.6.1 Europe Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032)
  12. 9.6.2 Europe Neurorehabilitation Revenue by Country (2021-2026)
  13. 9.6.3 Europe Neurorehabilitation Revenue by Country (2027-2032)
  14. 9.6.4 Germany
  15. 9.6.5 France
  16. 9.6.6 U.K.
  17. 9.6.7 Italy
  18. 9.6.8 Russia
  19. 9.6.9 Spain
  20. 9.6.10 Netherlands
  21. 9.6.11 Switzerland
  22. 9.6.12 Sweden
  23. 9.6.13 Poland
10 China
  1. 10.1 China Neurorehabilitation Revenue (2021-2032)
  2. 10.2 China Neurorehabilitation Revenue by Type (2021-2032)
  3. 10.2.1 China Neurorehabilitation Revenue by Type (2021-2026)
  4. 10.2.2 China Neurorehabilitation Revenue by Type (2027-2032)
  5. 10.3 China Neurorehabilitation Revenue Share by Type (2021-2032)
  6. 10.4 China Neurorehabilitation Revenue by Application (2021-2032)
  7. 10.4.1 China Neurorehabilitation Revenue by Application (2021-2026)
  8. 10.4.2 China Neurorehabilitation Revenue by Application (2027-2032)
  9. 10.5 China Neurorehabilitation Revenue Share by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Neurorehabilitation Revenue (2021-2032)
  2. 11.2 Asia Neurorehabilitation Revenue by Type (2021-2032)
  3. 11.2.1 Asia Neurorehabilitation Revenue by Type (2021-2026)
  4. 11.2.2 Asia Neurorehabilitation Revenue by Type (2027-2032)
  5. 11.3 Asia Neurorehabilitation Revenue Share by Type (2021-2032)
  6. 11.4 Asia Neurorehabilitation Revenue by Application (2021-2032)
  7. 11.4.1 Asia Neurorehabilitation Revenue by Application (2021-2026)
  8. 11.4.2 Asia Neurorehabilitation Revenue by Application (2027-2032)
  9. 11.5 Asia Neurorehabilitation Revenue Share by Application (2021-2032)
  10. 11.6 Asia Neurorehabilitation Revenue by Country
  11. 11.6.1 Asia Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032)
  12. 11.6.2 Asia Neurorehabilitation Revenue by Country (2021-2026)
  13. 11.6.3 Asia Neurorehabilitation Revenue by Country (2027-2032)
  14. 11.6.4 Japan
  15. 11.6.5 South Korea
  16. 11.6.6 India
  17. 11.6.7 Australia
  18. 11.6.8 Taiwan
  19. 11.6.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Neurorehabilitation Revenue (2021-2032)
  2. 12.2 SAMEA Neurorehabilitation Revenue by Type (2021-2032)
  3. 12.2.1 SAMEA Neurorehabilitation Revenue by Type (2021-2026)
  4. 12.2.2 SAMEA Neurorehabilitation Revenue by Type (2027-2032)
  5. 12.3 SAMEA Neurorehabilitation Revenue Share by Type (2021-2032)
  6. 12.4 SAMEA Neurorehabilitation Revenue by Application (2021-2032)
  7. 12.4.1 SAMEA Neurorehabilitation Revenue by Application (2021-2026)
  8. 12.4.2 SAMEA Neurorehabilitation Revenue by Application (2027-2032)
  9. 12.5 SAMEA Neurorehabilitation Revenue Share by Application (2021-2032)
  10. 12.6 SAMEA Neurorehabilitation Revenue by Country
  11. 12.6.1 SAMEA Neurorehabilitation Revenue by Country (2021 VS 2025 VS 2032)
  12. 12.6.2 SAMEA Neurorehabilitation Revenue by Country (2021-2026)
  13. 12.6.3 SAMEA Neurorehabilitation Revenue by Country (2027-2032)
  14. 12.6.4 Brazil
  15. 12.6.5 Argentina
  16. 12.6.6 Chile
  17. 12.6.7 Colombia
  18. 12.6.8 Peru
  19. 12.6.9 Saudi Arabia
  20. 12.6.10 Israel
  21. 12.6.11 UAE
  22. 12.6.12 Turkey
  23. 12.6.13 Iran
  24. 12.6.14 Egypt
13 Concluding Insights
    14 Appendix
    1. 14.1 Reasons for Doing This Study
    2. 14.2 Research Methodology
    3. 14.3 Research Process
    4. 14.4 Authors List of This Report
    5. 14.5 Data Source
    6. 14.5.1 Secondary Sources
    7. 14.5.2 Primary Sources

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst